MyGlowHow to keep a GLP-1 side-effect log your doctor can use
What to write down
- Symptom: nausea, vomiting, diarrhea, constipation, reflux, bloating, headache, tiredness, dizziness…
- Strength: 1 (barely noticeable) to 5 (stopped me from doing things).
- Timing: which day after your dose it happened.
- Context: dose change, what you ate, how much water you drank.
- What helped, if anything.
Why timing matters
Many people notice that side effects cluster in the first days after a dose or after a dose increase. When your log is tied to your dose history, that pattern shows up on its own.
Bring it to your appointment
"I felt sick sometimes" is hard to act on. "Nausea 3/5 on days 1–2 after each dose, for three weeks since the increase" is not. A short summary or a report from your tracking app makes the conversation faster.
When not to wait
Contact your clinician promptly for symptoms that are severe, persistent or worrying, such as severe stomach pain that won't go away, persistent vomiting, or signs of dehydration or an allergic reaction. In an emergency, call your local emergency number. Your medication's label lists the warning signs that apply to it.
Logging it in MyGlow
MyGlow's daily check-in records side effects, mood and energy next to your doses, and the doctor report puts it all on one page you can share.
Frequently asked questions
What are common side effects of GLP-1 medications?
The labels for GLP-1 medications list gastrointestinal effects such as nausea, vomiting, diarrhea and constipation among the most common. Your medication's label has the full list.
Why keep a side-effect log on a GLP-1?
A log tied to your dose dates shows patterns (for example, nausea after a dose increase) and gives your clinician specific information to adjust your plan.
When should I call my doctor about GLP-1 side effects?
Contact your clinician for severe, persistent or worrying symptoms, such as severe abdominal pain, persistent vomiting, dehydration or signs of an allergic reaction. In an emergency, call emergency services.